Yarrow Bioscience Inc (YARW) Options Chain

The options chain displays all available contracts with end-of-day quotes, Greeks, volume, and open interest for each strike and expiration, and streams live quotes for traders who connect a broker. It is the primary tool for options trade selection.

Yarrow Bioscience Inc (YARW) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $636,252, listed on NASDAQ, employing roughly 10 people, carrying a beta of 2.02 to the broader market. Yarrow Bioscience is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. Led by Rebecca Velez Frey, public since 2026-07-28.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for YARW as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →